2型炎症标志物与鼻息肉术后复发相关
这项单中心纵向研究随访了48例首次接受鼻内镜手术的慢性鼻窦炎伴鼻息肉患者,比较术后需修正手术者与药物控制者首次手术时的血液和鼻分泌物标志物。
要点
- 鼻分泌物IL-5、IgE和ECP升高与鼻息肉术后需修正手术相关。
- 血液标志物及哮喘、过敏等临床特征在复发组与对照组间无差异。
- 首次手术时鼻分泌物免疫谱可能有助于预测复发和治疗反应。
核心结论
- 以鼻分泌物采样的简单方法显示,2型辅助T细胞蛋白表达优势谱与ESS后CRSwNP复发相关。
- CRSwNP初期的免疫谱分析可能有助于更好地预测对最佳药物和手术治疗的反应,并帮助界定创新靶向治疗在糖皮质激素和ESS之外的作用。
研究设计与样本
- 单中心纵向研究,随访至2019年6月,纳入2010年12月至2012年1月间首次接受手术的CRSwNP患者。
- 在首次手术时建立血液和鼻分泌物生物标志物谱,检测IL-5、IgE、IgA、ECP和EDN。
- 比较随访期间仍由药物治疗控制与需修正手术的患者。
主要发现
- 两组患者首次手术时临床特征(哮喘、过敏、阿司匹林不耐受、主动吸烟)及血液标志物水平相当。
- 需修正手术组鼻分泌物中IL-5、IgE和ECP水平显著升高。
临床怎么用
- 可考虑在首次ESS时采集鼻分泌物检测IL-5、IgE和ECP,辅助识别术后复发高风险患者。
- 对鼻分泌物2型炎症标志物升高的CRSwNP患者,可加强术后随访和优化药物治疗。
局限性
- 单中心研究,初始样本量48例,需修正手术者仅8例。
- 随访至2019年6月,未报告多变量分析或预测阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite maximum medical treatment and endoscopic sinus surgery (ESS), chronic rhinosinusitis with nasal polyps (CRSwNP) can require revision surgery. With a growing literature on the diversity of cytokine inflammation patterns in CRSwNP, an endotype-driven approach could lead to the identification of cytokine profiles that predict recurrence. METHODS: A monocentric longitudinal study was carried out until June 2019 following CRSwNP patients who underwent surgery for the first time between December 2010 and January 2012. The biomarker profiles were established on blood and nasal secretions at the time of the first surgery (Interleukin (IL)-5, IgE, IgA, eosinophilic cationic protein (ECP) and eosinophilic- derived neurotoxin (EDN)). Profiles were compared between the patients still controlled by medical treatment and the patients requiring revision surgery during the course of the follow-up period. RESULTS: Among the 48 patients initially enrolled in our study, 8 required revision surgery (16,7%). Clinical features (asthma, allergy, aspirin intolerance, active smoking) and levels of blood markers measured at the time of the first surgery were comparable between the 2 groups of patients. Levels of IL-5, IgE and ECP in nasal secretions were significantly increased in the group of patients needing revision surgery. CONCLUSIONS: Based on simple approach of nasal secretions sampling, we showed that a predominant T helper 2 proteins expression profile can be associated with recurrent CRSwNP after ESS. Initial immunoprofiling in CRSwNP disease may contribute to better predict the therapeutic response to optimal medical and surgical treatment, and help define the role of innovative targeted treatment, beside corticosteroids and ESS.
引用
- Mortuaire G, Gengler I, Carpentier C, et al. T helper 2 inflammatory markers are associated with recurrence in chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery. Rhinology. 2020. PMID: 32369537. doi:10.4193/Rhin19.439
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。